Sitemap
Chris Chan

Chris Chan

Lead designer @ Twilio Segment. Passionate about travel, storytelling, and coffee

Joining Syapse

2 min readFeb 22, 2018

In 2010, my dad passed away from a decade-long battle with sarcoma, a rare form of cancer. I spent nearly my entire childhood on the sidelines of his battle—a battle marked by two polar opposites: the exhaustion of the countless surgeries, chemotherapy, and radiation treatments, and the hope that my dad could have, one day, overcome the disease.

Throughout those ten years, my dad worked with his oncologist to relentlessly enroll and participate in clinical trials all over the country. He made rounds at cancer centers at Stanford, Johns Hopkins, the University of Washington, and UCSF .

When he was diagnosed with cancer in 2000, the field of precision medicine —the practice of using each patient’s individual genetics to create a treatment protocol just for them—was in its infancy.

I now look back and think: How might genomic data have helped inform my dad’s situation? How might precision medicine have affected his outcome?

A few decades ago precision medicine in cancer treatment was just beginning—today, we are in a new era. Precision medicine is in an exciting time; genomics and molecular technologies are playing an increasingly critical role in everything from predicting cancer risk to improving cancer diagnosis and targeting cancer treatments.

Get Chris Chan’s stories in your inbox

Join Medium for free to get updates from this writer.

Of course, there remains many challenges for this practice, including the means to deliver precision medicine with speed and efficiency—all over the country, and even on a global scale.

This is why I am joining Syapse as a product designer.

Syapse is working on technology to implement precision medicine programs across health systems, moving towards a future in which cancer patients have access to the best precision care, regardless of income or location.

I’m excited by the company’s recent momentum, including a partnership that will democratize access to clinical trials, an expansion into Asia, and its continued collaboration with leaders in the precision cancer care ecosystem. I’m thrilled to see what the future holds for Syapse and for precision medicine.

Ever since I started designing software, I’ve continued to seek opportunities to work at the intersection of meaningful problems and technology. After witnessing my dad’s battle with cancer, I’ve kept a close eye on breakthroughs for treatments and approaches, with growing optimism for new developments.

Now, I’m excited to work with an incredible team on something I’m deeply passionate about. It’s uncharted territory and I’ve got a lot to learn. Yet I’m eager to get to work, and help build tools that will bring better treatments and outcomes to more people.

--

--

Chris Chan
Chris Chan

Written by Chris Chan

Lead designer @ Twilio Segment. Passionate about travel, storytelling, and coffee